AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...
A study by Oregon Health & Science University researchers has uncovered a new way proteins can be changed inside cells. This ...
Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on ...
A new consensus paper provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the ...
AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...
News-Medical.Net on MSN3h
Queen Mary scientists invent a new way to repair osteochondral defectsScientists at Queen Mary University of London have invented a new way to repair osteochondral defects – a common form of ...
In epidemiological, genetic, and intervention studies, mixed dyslipidaemia, characterised by elevated concentrations of total ...
Understand your treatment options with our A to Z guide to cancer treatment and drugs. Find out about different types of treatments and possible side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback